| scholarly article | Q13442814 |
| P50 | author | Johannes C Nossent | Q39367973 |
| P2093 | author name string | A J Swaak | |
| W Bronsveld | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course | Q33555951 | ||
| Prognostic factors in lupus nephritis. Contribution of renal histologic data | Q36600287 | ||
| Lupus nephropathy without clinical renal involvement | Q40822014 | ||
| Mortality in lupus nephritis | Q41668485 | ||
| The prognosis of lupus nephritis. Role of clinical-pathologic correlations | Q41940079 | ||
| Marginal benefit of renal biopsy in systemic lupus erythematosus | Q46126013 | ||
| The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
| Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis | Q57244973 | ||
| Renal damage in systemic lupus erythematosus with normal renal function | Q67494372 | ||
| Hypertension and renal disease in systemic lupus erythematosus | Q67806367 | ||
| Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
| Thirty-four-year delayed-onset lupus nephritis: a case report | Q69014634 | ||
| Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization | Q69437059 | ||
| Renal biopsy in SLE irrespective of clinical findings: long-term follow-up | Q69638600 | ||
| A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death | Q70245059 | ||
| Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980 | Q70279084 | ||
| The value of the renal biopsy in lupus nephritis | Q70422693 | ||
| "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients | Q70803184 | ||
| RENAL DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS | Q76499722 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 810-816 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively | |
| P478 | volume | 48 |
| Q50988300 | "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. |
| Q38831835 | A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran |
| Q35167886 | Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis |
| Q44590237 | Clinical renal involvement in Afro-Caribbean lupus patients. |
| Q34309764 | Combination treatment in autoimmune diseases: systemic lupus erythematosus. |
| Q47626474 | Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial |
| Q51570125 | Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. |
| Q44081617 | Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients |
| Q46423570 | Demographic differences in the development of lupus nephritis: a retrospective analysis |
| Q33565831 | Environmental factors predicting nephritis in systemic lupus erythematosus |
| Q21136392 | Identification of unique microRNA signature associated with lupus nephritis |
| Q46592474 | Outcomes in African Americans and Hispanics with lupus nephritis. |
| Q57371324 | Rituximab induced pulmonary fibrosis in a patient with lupus nephritis |
| Q33584094 | Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation |
| Q36727769 | The significance of arterial hypertension at the onset of clinical lupus nephritis |
| Q36840264 | Treatment of systemic lupus erythematosus: which options do we have for therapy regimens? |
Search more.